Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Manchester will host the inaugural World Healthcare Congress Europe (5-7 March, 2019), providing a global platform to showcase health and social care innovation. Professor Chris Griffiths will be leading a session on stratified approaches to healthcare session at the Congress.
Continue reading full article: Manchester chosen to host World Healthcare Congress Europe 2019
Join us to find out about research taking place in Manchester for BSL Users.
Continue reading full article: Deaf BSL Users in Research
Dr Rebecca Lee provides an insight into life as a NIHR Manchester BRC PhD student.
Continue reading full article: Six months in the life of a PhD student
Health Innovation Manchester has strengthened its leadership team with two key appointments including Professor Ian Bruce as Research Director.
Continue reading full article: Clinical leaders appointed to drive innovation across Greater Manchester
Protease modulating therapies are used to assist in venour leg ulcer closure, but a recent review suggests that physicans should rexamine the biomarker's role in targeted chronic wound healing therapies.
Continue reading full article: Role of protease targets in wound healing uncertain
Greater Manchester resident, Gen Buckley, who lost her father and brother early to bowel cancer, is urging the public to support new health research by sharing their ideas about saving lives from cancer.
Continue reading full article: Twice bereaved relative appeals to public for early detection ideas to save lives from cancer
On World COPD Day, Professor Jørgen Vestbo, Respiratory Theme Lead and COPD Programme Co-Lead for Manchester BRC, reflects on the status and management of COPD and reminds us that we shouldn’t overlook this devastating disease.
Continue reading full article: Recognising the importance of COPD awareness and research
During World Antibiotic Awareness Week, Dr Alexander Mathioudakis, BRC Clinical Fellow discusses how the TRACE-COPD trial is using blood tests to guide and target the administration of antibiotics and oral steroids.
Continue reading full article: Using precision medicine to reduce unnecessary use of antibiotics for COPD flare-up